- Home
- Equipment
- canada saskatchewan
- vaccine recombinant
Refine by
Vaccine Recombinant Equipment & Supplies Near Saskatchewan
8 equipment items found
Manufactured by:Dynavax Technologies Corporation based inEmeryville, CALIFORNIA (USA)
HEPLISAV-B is indicated for prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older.1 ...
Manufactured by:Novavax based inGaithersburg, MARYLAND (USA)
Our recombinant nanoparticle vaccine technology combines the power and speed of genetic engineering to efficiently produce a new class of highly immunogenic particles that target a variety of viral pathogens. Our recombinant vaccine engineering takes a new approach to provide robust and functional immunity, which may be more ...
Manufactured by:Lipotek based inActon, AUSTRALIA
Lipokel is a self adjuvanting small molecule suitable for the formulation of recombinant protein vaccines. Lipokel is very effective at stimulating TLR2 receptors and can be formulated for nasal delivery of vaccines in powder ...
Manufactured by:Calder Biosciences, Inc. based inBrooklyn, NEW YORK (USA)
Targeted approach, focused responses. Substantially reduced risk vis-à-vis other modalities. Successful recombinant subunit vaccines elicit the highest. Ab responses; Shingrix vs. Zostavax, Gardasil, HBsAg (Recombivax, Engerix, Heplisav), HAV (Vaqta, ...
Manufactured by:ProBioGen AG based inBerlin, GERMANY
All our proprietary cell lines are characterized by excellent productivity, safety, and stability. They are used in the industrial production of virus-based vaccines or recombinant proteins and are suitable for the manufacture of human and animal ...
Manufactured by:Altimmune Inc. based inGaithersburg, MARYLAND (USA)
A recombinant intranasal vaccine that is being developed for both seasonal and pandemic use. NasoVAX can activate the humoral, mucosal and cellular immune arms in unison for a more comprehensive immune response. The data from our Phase 2a trial with a monovalent NasoVAX vaccine indicated that NasoVAX was well-tolerated and achieved 100% ...
Manufactured by:Akshaya Bio Inc. based inEdmonton, ALBERTA (CANADA)
The Chimigen® Platform is a flexible platform vaccine technology designed to elicit both humoral and cellular immune responses in ...
by:Aphios Corporation based inWoburn, MASSACHUSETTS (USA)
Vaccination is the most cost-effective tool for the control and prevention of infectious diseases. However, multiple inoculations are often required to achieve desirable protection even with potent antigens. In order to increase the therapeutic efficiency of such vaccines, adjuvants are used with vaccines to augment the immune response. There are several types of adjuvants with different modes of ...